Skip to main content
. Author manuscript; available in PMC: 2015 Oct 23.
Published in final edited form as: Pediatrics. 2013 Aug 12;132(3):e604–e611. doi: 10.1542/peds.2013-1002

Table 1.

Selected characteristics of Florida-born infants with critical congenital heart disease (CCHD) (n=3,603), 1998-2007

Characteristic Infants with timely
detected CCHD
(n=2,778)
n (%)
Infants with late
detected CCHD
(n=825)
n (%)
Unadjusted
prevalence ratio
(95% confidence
interval)
Maternal / household

Mother’s age, years
 ≤ 24 945 (34.0) 321 (38.9) 1.2 (1.0-1.3)
 25-34 1,338 (48.2) 376 (45.6) Reference
 ≥ 35 495 (17.8) 128 (15.5) 0.8 (0.7-1.0)
Mother’s race / ethnicity
 White, non-Hispanic 1,495 (53.9) 470 (57.0) Reference
 Black, non-Hispanic 621 (22.4) 178 (21.6) 1.0 (0.8-1.1)
 Hispanic 586 (21.1) 155 (18.8) 0.9 (0.8-1.1)
 Asian / Pacific Islander and American Indian /
 Alaskan
50 (1.8) 17 (2.1) 1.0 (0.6-1.5)
Mother’s education
 Less than high school graduate 564 (20.3) 177 (21.5) 1.1 (0.9-1.3)
 High school graduate or equivalent 912 (32.8) 304 (36.9) 1.2 (1.1-1.4)
 College or university (some or graduate) 1,275 (45.9) 340 (41.2) Reference
Mother’s nativity: foreign-born 677 (24.4) 163 (19.8) 0.8 (0.7-0.9)
Principal healthcare payer type on birth hospitalization
recorda
 Private 1,324 (47.7) 377 (45.7) Reference
 Public 1,360 (49.0) 409 (49.6) 1.1 (0.9-1.2)
 Self-Insured/Uninsured 94 (3.4) 39 (4.7) 1.3 (0.9-1.7)
Birth hospital nursery level
 I 425 (15.3) 250 (30.3) 2.1 (1.8-2.4)
 II 598 (21.5) 214 (25.9) 1.5 (1.3-1.8)
 III 1,755 (63.2) 361 (43.8) Reference

Infant

Sex, female 1,195 (43.0) 361 (43.8) 1.0 (0.9-1.2)
Preterm or very preterm birth (20-36 weeks) 595 (21.4) 143 (17.3) 0.8 (0.7-0.9)
Non-cardiac congenital anomaly 883 (31.8) 250 (30.3) 0.9 (0.8-1.1)
Plurality, multiple gestation 54 (1.9) 9 (1.1) 0.7 (0.4-1.3)
Critical congenital heart disease (CCHD) typeb,c
Single condition
 Hypoplastic left heart syndrome (HLHS)c 196 (7.1) 27 (3.3) Reference
 Aortic interruption/atresia/hypoplasia (AI/A) 70 (2.5) 26 (3.2) 2.2 (1.4-3.6)
 Coarctation/hypoplasia of aortic arch (COA) 472 (17.0) 275 (33.3) 3.0 (2.1-4.4)
 Double-outlet right ventricle (DORV) 77 (2.8) 32 (3.9) 2.4 (1.5-3.8)
 Dextro-transposition of the great arteries (d-TGA)c 234 (8.4) 26 (3.2) 0.8 (0.5-1.4)
 Ebstein anomaly (EA) 76 (2.7) 11 (1.3) 1.0 (0.5-2.0)
 Pulmonary atresia (PA)c 74 (2.7) 22 (2.7) 1.9 (1.1-3.2)
 Single ventricle (SV) 24 (0.9) 8 (1.0) 2.1 (1.0-4.1)
 Truncus arteriosus (TA)c 69 (2.5) 32 (3.9) 2.6 (1.7-4.1)
 Total anomalous pulmonary venous connection
 (TAPVC)c
55 (2.0) 37 (4.5) 3.3 (2.2-5.1)
 Tetralogy of Fallot (TOF)c 561 (20.2) 184 (22.3) 2.0 (1.4-3.0)
 Tricuspid atresia (TRA)c 102 (3.7) 20 (2.4) 1.4 (0.8-2.3)
Multiple conditions 768 (27.7) 125 (15.2) 0.5 (0.4-0.7)
Year of birth
 1998 247 (8.9) 73 (8.9) 1.1 (0.8-1.5)
 1999 234 (8.4) 86 (10.4) 1.3 (0.9-1.7)
 2000 268 (9.7) 77 (9.3) 1.2 (0.9-1.6)
 2001 238 (8.6) 90 (10.9) 1.4 (1.1-1.9)
 2002 265 (9.5) 73 (8.9) 1.0 (0.8-1.4)
 2003 276 (9.9) 77 (9.3) 1.2 (0.9-1.6)
 2004 264 (9.5) 106 (12.9) 1.4 (1.1-1.9)
 2005 331 (11.9) 69 (8.4) 0.9 (0.6-1.2)
 2006 322 (11.6) 82 (9.9) 0.9 (0.7-1.2)
 2007 333 (12.0) 79 (9.6) Reference

Bold results indicate p-value <0.05

a

Private insurance included employer-based insurance (including Tricare). Public insurance included Medicare, Medicaid, Veteran’s Administration insurance, and other state and local government health insurance in Florida, such as KidCare.

b

CCHD identified by ICD-9-CM codes: HLHS: 746.7, AI/A: 747.11, 747.22; COA: 747.10; DORV: 745.11; d-TGA: 745.10; EA: 746.2; PA: 746.01; SV: 745.3; TA: 745.0; TAPVC: 747.41; TOF: 745.2; TRA: 746.1.

c

Primary targets for pulse oximetry screening.1,14,15